Early research (Phase 1)Study completedNCT01335347What this trial is testingSafety Study of an Oral Vaccine to Prevent Avian InfluenzaWho this might be right forAvian InfluenzaBird Flu Vaxart 54
Testing effectiveness (Phase 2)Study completedNCT00506350What this trial is testingEvaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed AdultsWho this might be right forInfluenza GlaxoSmithKline 350
Testing effectiveness (Phase 2)Study completedNCT01035749What this trial is testingStudy of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 YearsWho this might be right forInfluenza GlaxoSmithKline 310
Testing effectiveness (Phase 2)Study completedNCT00953524What this trial is testingDifferent Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the ElderlyWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 849
Not applicableStudy completedNCT01101074What this trial is testingObservational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived VaccineWho this might be right forInfluenza A (H1N1) Novartis Vaccines 135,469
Testing effectiveness (Phase 2)Study completedNCT05972174What this trial is testingMRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy AdultsWho this might be right forInfluenza ModernaTX, Inc. 1,504
Not applicableStudy completedNCT01282177What this trial is testingInfluenza Vaccine Safety and Effectiveness in Healthcare ProvidersWho this might be right forInfluenza Dalhousie University 1,143
Large-scale testing (Phase 3)Study completedNCT00841763What this trial is testingSafety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly SubjectsWho this might be right forPandemic Influenza Disease Novartis 3,647
Not applicableStudy completedNCT01298206What this trial is testingCase-control Study of Pandemic A/H1N1 Influenza Risk Factors In LebanonWho this might be right forA/H1N1 InfluenzaSwine Flu St. Jude Children's Research Hospital 129
Large-scale testing (Phase 3)Study completedNCT01987011What this trial is testingPhase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult VolunteersWho this might be right forInfluenza Green Cross Corporation 420
Post-approval studies (Phase 4)UnknownNCT01151644What this trial is testingSafety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesWho this might be right forRheumatoid ArthritisSpondyloarthritisSystemic Lupus Erythematosus (SLE)+9 more University of Sao Paulo 5,000
Large-scale testing (Phase 3)Study completedNCT01382329What this trial is testingH5N1 Vaccine Study in Japanese AdultsWho this might be right forH5N1 Influenza Alachua Government Services, Inc. 340
Not applicableStudy completedNCT01192737What this trial is testing"COhort Study on A/H1N1 FLU During PREGnancy"Who this might be right forInfluenzaPregnancy Institut National de la Santé Et de la Recherche Médicale, France 919
Not applicableStudy completedNCT01000571What this trial is testingImmunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young AdultsWho this might be right forH1N1 Pandemic Flu St. Jude Children's Research Hospital 104
Post-approval studies (Phase 4)Study completedNCT01114620What this trial is testingStudy of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or OlderWho this might be right forInfluenza GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT06179446What this trial is testingLearn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic InfluenzaWho this might be right forGrippeInfluenzaVaccines Pfizer 157
Early research (Phase 1)Study completedNCT00488046What this trial is testingSingle Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 16
Testing effectiveness (Phase 2)Study completedNCT00956202What this trial is testingInactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 YearsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 303
Testing effectiveness (Phase 2)Study completedNCT00415129What this trial is testingSafety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the ElderlyWho this might be right forInfluenzaOrthomyxoviridae Infections Sanofi Pasteur, a Sanofi Company 600
Early research (Phase 1)Study completedNCT00984945What this trial is testingSafety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy AdultsWho this might be right forVirus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more Medicago 48